Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Maintenance of remission · maintenance of remission in Crohn's disease

It is very uncertain whether azathioprine and infliximab changes maintenance of remission compared with infliximab (very low certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 1.02 [0.74, 1.4]
1 study · 36 participants
Very low

Adverse events · maintenance of remission in Crohn's disease

It is very uncertain whether azathioprine and infliximab changes adverse events compared with infliximab (very low certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 1.6 [0.33, 7.86]
1 study · 45 participants
Very low

Withdrawals due to adverse events · maintenance of remission in Crohn's disease

It is very uncertain whether azathioprine and infliximab changes withdrawals due to adverse events compared with infliximab (very low certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 2.42 [0.1, 56.46]
1 study · 45 participants
Very low

Serious adverse events · maintenance of remission in Crohn's disease

It is very uncertain whether azathioprine and infliximab changes serious adverse events compared with infliximab (very low certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 2.42 [0.1, 56.46]
1 study · 45 participants
Very low